News | Radiation Therapy | March 28, 2023

People exposed to low doses of ionizing radiation have an extra, but modest, risk of developing heart disease during their lifetime, according to a new study

People exposed to low doses of ionizing radiation have an extra, but modest, risk of developing heart disease during their lifetime, according to a new study

Getty Images


March 28, 2023 — People exposed to low doses of ionizing radiation have an extra, but modest, risk of developing heart disease during their lifetime, according to a new study published by an international consortium of researchers.

“The study suggests that radiation exposure, across a range of doses, may be related to an increased risk of not just cancer, as has been previously appreciated, but also of cardiovascular diseases,” says Andrew Einstein, MD, PhD, professor of medicine at Columbia University Vagelos College of Physicians and Surgeons and one of the study’s senior authors.

“It should not steer people away from receiving radiation if necessary—in fact many medical uses of radiation are lifesaving—but it underscores the importance of ensuring that radiation is used appropriately and kept as low as reasonably achievable.”

It’s well known that exposure to high doses of radiation, from cancer therapy for example, can damage the heart. But firm evidence linking heart disease with low-dose radiation—encountered by workers in the nuclear industry or from diagnostic medical imaging—is less clear.

The researchers used data from 93 studies covering all ranges of radiation exposures to find a relationship between dose and heart disease.

They found an increased excess lifetime risk of 2.3 to 3.9 cardiovascular deaths per 100 persons exposed to one Gy of radiation. (In the United States, about 25 out of every 100 people die from cardiovascular disease; a person exposed to 1 Gy of radiation will have a slightly higher, 27% to 29%, risk of dying from cardiovascular disease).

Few people other than those receiving radiation therapy will receive 1 Gy during their lives. But the researchers also found a higher risk of heart disease at low dose ranges (<0.1 Gy) more commonly experienced by the public and also for protracted exposures to low doses.

More research is needed to determine the precise increased excess lifetime risk of heart disease from these low doses.

“The effect of lower doses of radiation on the heart and blood vessels may have been underestimated in the past,” Einstein says. “Our new study suggests that guidelines and standards for protection of workers exposed to radiation should be reconsidered, and efforts to ensure optimal radiation protection of patients should be redoubled.”

The study, titled “Ionising radiation and cardiovascular disease: systematic review and meta-analysis,” was published March 8 in The BMJ.

The corresponding author is Mark P. Little, DPhil, senior investigator at the National Cancer Institute.

Andrew J. Einstein, MD, PhD, is a cardiologist and researcher at Columbia University and New York-Presbyterian. He also is director of nuclear cardiology, cardiac CT, and cardiac MRI and director of the advanced cardiac imaging fellowship.

Other authors: Tamara V. Azizova (Southern Urals Biophysics Institute, Russia); David B. Richardson (University of California Irvine); Soile Tapio (Technische Universität München); Marie-Odile Bernier (Institut de Radioprotection et de Sureté Nucléaire, France); Michaela Kreuzer (Federal Office for Radiation Protection, Germany); Francis A Cucinotta (University of Nevada Las Vegas); Dimitry Bazyka (National Academy of Medical Sciences of Ukraine); Vadim Chumak (National Academy of Medical Sciences of Ukraine); Victor K. Ivanov (Russian Academy of Medical Sciences); Lene H.S. Veiga (National Cancer Institute); Alicia Livinski (National Institutes of Health); Kossi Abalo (Karolinska Institutet and Uppsala University); Lydia B. Zablotska (University of California, San Francisco); and Nobuyuki Hamada (Central Research Institute of Electric Power Industry, Japan).

For more information: https://www.cuimc.columbia.edu/


Related Content

News | Radiation Therapy

May 23, 2024 — RaySearch Laboratories AB and C-RAD announced a collaboration agreement, aiming at jointly developing ...

Time May 23, 2024
arrow
News | Artificial Intelligence

May 22, 2024 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, recently ...

Time May 22, 2024
arrow
News | Oncology Information Management Systems (OIMS)

May 21, 2024 — RaySearch Laboratories AB announced that the oncology information system RayCare* 2024A has been ...

Time May 21, 2024
arrow
News | Proton Therapy

May 21, 2024 — IBA, a world leader in particle accelerator technology, announced that it has signed a contract with the ...

Time May 21, 2024
arrow
News | Radiology Business

May 20, 2024 — Associated Medical Professionals of NY (A.M.P.) announced that internationally recognized radiation ...

Time May 20, 2024
arrow
News | ASTRO

May 17, 2024 — Registration opens today for the American Society for Radiation Oncology's (ASTRO) 66th Annual Meeting ...

Time May 17, 2024
arrow
News | Radiation Therapy

May 16, 2024 — Today marks a significant milestone in cancer care with the introduction of bipartisan federal ...

Time May 16, 2024
arrow
News | FDA

May 14, 2024 — Indica Labs, the leading provider of digital pathology solutions, announced today that it received FDA ...

Time May 14, 2024
arrow
News | Radiology Business

May 14, 2024 — University Hospitals (UH) and Siemens Healthineers announce a 10-year strategic alliance that builds on ...

Time May 14, 2024
arrow
News | Artificial Intelligence

May 14, 2024 — Elekta announced the launch of its latest linear accelerator (linac), Evo*, a CT-Linac with new high ...

Time May 14, 2024
arrow
Subscribe Now